Maintaining genome stability is critical for mammalian development, and is achieved by the functional integration of DNA replication and DNA damage signaling^[@R1]--[@R4]^. This is particularly important during neural development, where defective DNA damage signaling can result in a wide spectrum of human diseases that are characterized by neurodegeneration, neurodevelopmental disease or brain tumors^[@R5]^. However, little is known about specific factors that modulate and maintain stem and progenitor genome integrity *in vivo* during neurogenesis.

Topoisomerase II binding protein 1 (TopBP1) is important for DNA replication initiation and cell cycle checkpoint activation^[@R6]--[@R10]^. Mammalian TopBP1 contains eight BRCA1 C-terminal (BRCT) domains that facilitate protein-protein interactions between key replication and checkpoint factors^[@R11]--[@R14]^. TopBP1 has been linked to the pre-replication complex because, together with factors such as TRESLIN/Ticrr and GEMC1, it is required for loading essential replication initiation components including Cdc45^[@R6],\ [@R9],\ [@R10],[@R15]^.

DNA damage arises during replication via frequent stalled replication forks or when DNA breaks occur by free radicals generated during cellular metabolism^[@R1],\ [@R15],\ [@R16]^. When replication forks stall, TopBP1 is important for initiating a cellular checkpoint. In this capacity, a key function appears to be activation of the ataxia telangiectasia and rad3-related (ATR) kinase to facilitate establishment of a checkpoint by phosphorylation of Chk1^[@R8],\ [@R17]--[@R20]^. The TopBP1-ATR-Chk1 signaling axis is key to DNA damage resolution during replication. When any of these factors are inactivated in the mammalian germline, replication failure occurs resulting in embryonic lethality^[@R13],\ [@R21]--[@R23]^. Many essential cellular components interface with TopBP1 to establish ATR-dependent checkpoint activation. These include the Rad9-Rad1-Hus1 (9-1-1) complex; a DNA binding clamp that is loaded onto DNA by Rad17 in response to DNA damage^[@R24]--[@R26]^. TopBP1 then interacts with this complex via Rad9 in a damage-dependent manner to facilitate ATR activation; this occurs through TopBP1 binding to ATRIP, the obligate ATR binding partner^[@R19],\ [@R25],\ [@R27],[@R28]^. This is a key event in the response to DNA damage as ATR is inactive until stimulated by TopBP1^[@R17]^. Other factors are also important in TopBP1 function during establishment of the replication checkpoint. These include the BACH1/FANCJ helicase and RHINO, which can bind TopBP1 to modulate ATR activation^[@R29]--[@R31]^.

While *in vitro* data indicate TopBP1 is critical for DNA replication, the physiological settings requiring this function are unknown. Here we show that there is a broad requirement for TopBP1 throughout neurogenesis where it functions to prevent DNA damage accumulation in progenitor cells. Notably, unlike ATR inactivation^[@R32],\ [@R33]^, DNA damage signaling after TopBP1 loss is p53-dependent. Finally, our data show that TopBP1 is not essential *per se* for replication; rather, the critical biological function of this protein during neurogenesis is most likely the activation of cellular checkpoints after replication-associated DNA damage.

Results {#S1}
=======

Neural inactivation of TopBP1 {#S2}
-----------------------------

To understand the biological function of TopBP1 we determined its role in the nervous system, as this tissue is often primarily affected in human syndromes associated with DNA repair deficiency^[@R5]^. We generated a *TopBP1* allele in which *LoxP* sites flank exons 3--6, which resulted in an out-of-frame mutation when cre recombinase is used to drive gene deletion ([Fig. 1a](#F1){ref-type="fig"}). We used *Nestin-cre* (*Nes-cre*) to generate *TopBP1^Nes-cre^* mice in which TopBP1 was inactivated throughout the nervous system. In *TopBP1^Nes-cre^* mice, TopBP1 was efficiently inactivated in neural tissues, while in non-neural tissues, such as the thymus and spleen, normal protein levels were present ([Fig. 1b](#F1){ref-type="fig"}). *TopBP1^Nes-cre^* mice were viable and were similar in size to wild-type littermates at birth, although they became runted within a week ([Fig. 1c](#F1){ref-type="fig"}) and generally did not survive beyond two weeks of age.

*TopBP1^Nes-cre^* mice were characterized by neurodevelopmental abnormalities ([Fig. 1d](#F1){ref-type="fig"} and [Suppl. Fig. 1](#SD1){ref-type="supplementary-material"}). We found a general reduction in cellularity in the *TopBP1^Nes-cre^* brain and a pronounced defect in cerebellar development. Analysis of the postnatal day 0 (P0) cerebellum showed disorganized Purkinje cells and an absence of an external granule layer (EGL), which resulted from apoptosis in the rhombic lip during development ([Fig. 1d](#F1){ref-type="fig"} and see later). Elsewhere, less striking effects were observed, although the hippocampal region was also markedly affected ([Suppl. Fig. 1](#SD1){ref-type="supplementary-material"}). Additionally, developmental gliogenesis was similar in *TopBP1^Nes-cre^* tissue to controls ([Suppl. Fig 2](#SD1){ref-type="supplementary-material"}).

TopBP1 loss affects cortical development {#S3}
----------------------------------------

To further determine the role of TopBP1 during neural development, we focused on cortical development, which commences from embryonic day 10.5 (E10.5)^[@R34],\ [@R35]^. We initially determined *TopBP1* gene deletion levels and protein loss in the *TopBP1^Nes-cre^* developing cortex. Quantitative analysis of isolated neopallium using real-time PCR indicated that *TopBP1* deletion was maximal between E12.5 and E13.5 ([Fig. 1e](#F1){ref-type="fig"}), and Western blot analysis confirmed TopBP1 protein was absent at E14.5 ([Fig. 1f](#F1){ref-type="fig"}). Of note, TopBP1 loss led to p53 phosphorylation, consistent with DNA damage-induced activation of p53 ([Fig. 1f](#F1){ref-type="fig"}). TopBP1 deletion resulted in widespread apoptosis by E13.5 as shown by terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) positive cells in the ventricular zone (VZ) of the developing cortex ([Fig. 1g](#F1){ref-type="fig"}). These proliferating areas also accumulated DNA damage as revealed by immunostaining for phosphorylated H2AX (γH2AX), which occurred early and was widespread between E11.5 and E12.5, and preceded apoptosis ([Suppl. Fig. 3a,b](#SD1){ref-type="supplementary-material"}). Analysis of cell types undergoing apoptosis indicated that BLBP-positive radial glial progenitors were largely intact, although they contained γH2AX (data not shown), indicating that TopBP1 loss was associated with apoptosis of newborn progenitors as abundant overlap between TUNEL- and PCNA-positive cells occurred at E16.5 ([Fig. 2a](#F2){ref-type="fig"}). Moreover, apical progenitors identified by phospho-histone H3 immunostaining were intact and largely unperturbed in *TopBP1^Nes-cre^* tissue at E13.5.

Apoptosis in the *TopBP1^Nes-cre^* neocortex resulted in an overall reduction in cortical size ([Suppl. Fig. 1b](#SD1){ref-type="supplementary-material"}). The cortex comprises six layers derived from inside-out patterning, with early cortical progenitors fated to produce deep-layer (layers VI--V) neurons^[@R34],\ [@R35]^. To determine how TopBP1 deletion during progenitor proliferation and differentiation affected layering in the *TopBP1^Nes-cre^* cortex we used layer-specific markers. Analysis at P0 and P10 using Tbr1 and Ctip2 showed that the deep layers (Layers VI--V) formed to a large extent in the *TopBP1^Nes-cre^* cortex ([Fig. 2c](#F2){ref-type="fig"}). In contrast, upper cortical layers identified by Cux1, Brn2 and Satb2 immunostaining, were reduced in size, suggesting persistent DNA damage in longer-cycling progenitors^[@R36]^ eventually compromised upper cortical layers ([Fig. 2c](#F2){ref-type="fig"}).

Expansion of Emx1 cortical progenitors requires TopBP1 {#S4}
------------------------------------------------------

Our data indicate that despite efficient deletion of *TopBP1* during neurogenesis substantial cortical development occurs in the *TopBP1^Nes-cre^* brain. Given the *in vitro* studies identifying a crucial role for TopBP1 function during replication^[@R9],\ [@R13]^, the large amount of cell proliferation associated with neurogenesis in the *TopBP1^Nes-cre^* tissue was unexpected.

To understand these findings we considered if the timing of gene deletion influences the outcome of TopBP1 inactivation. We assessed this using *Emx1-cre* to drive *TopBP1* deletion in early cortical progenitors. *Emx1-cre* expresses in the dorsal telencephalon earlier than *Nestin-cre* (i.e. \~E10 vs. E11)^[@R37],\ [@R38]^. *Emx1-cre* expression occurs in cells that give rise to the hippocampus and parts of the motor, somatosensory and visual cortex, but does not express in the ventral telencephalon^[@R37],\ [@R38]^. In striking contrast to *TopBP1^Nes-cre^*, there was a loss of all cortical structures derived from Emx1-expressing progenitors in *TopBP1^Emx1-cre^* mice ([Fig. 3a](#F3){ref-type="fig"} and [Suppl. Fig. 4a](#SD1){ref-type="supplementary-material"}). To ascertain the cause of this phenotype, we examined the embryonic neocortex at E13.5, when Emx1-expressing progenitors are rapidly expanding^[@R37]^. In *TopBP1^Emx1-cre^*, but not control tissue, we found abundant apoptosis indicated by activated caspase-3 immunostaining, TUNEL and resultant reduced cellularity after hematoxylin and eosin staining ([Fig. 3b](#F3){ref-type="fig"} and [Suppl. Fig. 4b](#SD1){ref-type="supplementary-material"}). Cell loss was also evident by reduced BrdU incorporation and fewer H3pS10 positive G2/M phase cells at the ventricular/apical surface ([Fig. 3c](#F3){ref-type="fig"}, arrows). This extensive cell loss is sufficient to account for the absence of the cortices at birth. We also found that TopBP1 inactivation led to widespread γH2AX immunostaining by E11.5 that co-localized with proliferating PCNA-positive cells in the dorsal telencephalon ([Suppl. Fig. 4c](#SD1){ref-type="supplementary-material"}). While the dorsal telencephalon was affected in the *TopBP1^Emx1-cre^* brain, other regions including the ventral telencephalon and the cerebellum showed no developmental abnormalities, underscoring the specificity of *Emx1-cre* expression ([Suppl. Fig. 4d](#SD1){ref-type="supplementary-material"}).

Emx1 progenitors proliferate after Lig4 or Xrcc1 loss {#S5}
-----------------------------------------------------

To further gauge the essential requirement for TopBP1 in the cortical progenitors, we determined the comparative importance of the key DNA repair factors DNA ligase IV (Lig4) and Xrcc1. These factors are central for DNA strand break repair via non-homologous end-joining and base excision repair respectively; germ line deletion of either is embryonic lethal and deletion throughout the nervous system using *Nestin-cre* results in microcephaly and DNA damage accumulation^[@R39],\ [@R40]^.

We therefore compared cortical development in *Lig4^Emx1-cre^* and *Xrcc1^Emx1-cre^* to *TopBP1^Emx1-cre^* mice. Loss of Lig4 or Xrcc1 resulted in cortices with milder developmental perturbations, although a marked effect upon the hippocampus was apparent ([Fig. 4a](#F4){ref-type="fig"}). Accordingly, cortical layering was relatively intact in both the *Lig4^Emx1-cre^* and *Xrcc1^Emx1-cre^* mice with each of the six layers present ([Fig. 4b](#F4){ref-type="fig"}). Nonetheless, substantial levels of DNA damage accumulated, as γH2AX was abundant in *Lig4^Emx1-cre^* tissue, consistent with *Lig4* gene deletion throughout the dorsal cortex leading to persistent unrepaired DNA ([Fig. 4c](#F4){ref-type="fig"}). These data indicate that despite the essential neural repair functions of Lig4 and Xrcc1, TopBP1 fulfills a unique role in maintaining genome stability of progenitors.

Progenitor loss after TopBP1 inactivation requires p53 {#S6}
------------------------------------------------------

In the nervous system, DNA damage-induced apoptosis is often p53- or Atm-dependent^[@R41]^. To determine if this signaling pathway contributed to the *TopBP1-*deleted phenotype, we generated compound *TopBP1* mutants with either coincident *p53* or *Atm* deletion.

Loss of p53 resulted in an obvious amelioration of the *TopBP1^Nes-cre^* cortical defects that were particularly noticeable in the case of hippocampal development, although this rescue was only partial ([Fig. 5a](#F5){ref-type="fig"} and [Suppl. Fig. 5a](#SD1){ref-type="supplementary-material"}). Notably, widespread DNA damage was observed in the rescued *TopBP1^Nes-cre^;p53^−/−^* dentate gyrus, indicating that chronic genome instability was a feature of this tissue ([Fig. 5a](#F5){ref-type="fig"} and [Suppl. Fig. 6a,b](#SD1){ref-type="supplementary-material"}). Consistent with this developmental rescue, apoptosis resulting from TopBP1 loss was also abrogated in *TopBP1^Nes-cre^;p53^−/−^* tissue and cell proliferation was recovered as determined by histone H3 phosphorylation ([Fig. 5b](#F5){ref-type="fig"}). However, in contrast to p53 loss, inactivation of *Atm* did not influence the *TopBP1*-null phenotype ([Fig. 5a,b](#F5){ref-type="fig"}). The rescue of the *TopBP1^Nes-cre^* phenotype by p53 also occurred in other *TopBP1^Nes-cre^* brain regions. The E13.5 *TopBP1^Nes-cre^* embryonic cerebellum showed apoptosis in proliferating cells of the ventricular zone, which was blocked after loss of p53, but not Atm ([Suppl. Fig. 7a](#SD1){ref-type="supplementary-material"}). Quantification of both proliferation and apoptosis showed that inactivation of p53 blocked apoptosis and restored proliferation to WT levels in the *TopBP1^Nes-cre^;p53^−/−^*cerebellum and ganglionic eminence, while Atm loss worsened the phenotype somewhat ([Suppl. Fig. 7b](#SD1){ref-type="supplementary-material"}).

Although rescue of the *TopBP1^Nes-cre^* phenotype by p53-loss was extensive, it only extended the lifespan of the *TopBP1^Nes-cre^* mice by around 10 days ([Suppl. Fig. 5b](#SD1){ref-type="supplementary-material"}). This likely reflects the profound functional consequence of persistent DNA damage after TopBP1 loss in replicating cells throughout the brain. These data indicate that DNA damage-associated apoptosis after TopBP1 loss is p53-dependent and that cells can proliferate in the absence of TopBP1, but at the expense of DNA damage accumulation.

Given the level of development in *TopBP1^Nes-cre^;p53^−/−^* neural tissue, we also determined how p53 inactivation impacted tissue loss in the *TopBP1^Emx1-cre^* brain and found a remarkable degree of cortical development in the *TopBP1^Emx1-cre^;p53^−/−^* mice ([Fig. 5c](#F5){ref-type="fig"}; red dashed lines). This rescue resulted in establishment of cortical layering, albeit less organized compared to WT tissue ([Fig. 5d](#F5){ref-type="fig"}). Most notably, the upper cortical layers were more affected, probably as a result of chronic DNA damage during neurogenesis. Recovered development in *TopBP1^Emx1-cre^;p53^−/−^* tissue showed perturbation of homeostasis as these regions were marked by gliosis ([Suppl. Fig. 6c, d](#SD1){ref-type="supplementary-material"}). One exception to the rescue in the *TopBP1^Emx1-cre^;p53^−/−^* tissue was the hippocampus, as this structure was absent from the *TopBP1^Emx1-cre^;p53^−/−^* brain ([Fig. 5c](#F5){ref-type="fig"}). This situation contrasts the partially recovered hippocampal development in the *TopBP1^Nes-cre^;p53^−/−^* brain ([Fig. 5a](#F5){ref-type="fig"}). The different hippocampal phenotypes between the *TopBP1^Emx1-cre^;p53^−/−^* and *TopBP1^Nes-cre^;p53^−/−^* likely reflect the enhanced sensitivity of early hippocampal progenitors towards genotoxic stress in the absence of TopBP1. The *TopBP1^Emx1-cre^;p53^−/−^* cortex was also associated with γH2AX immunopositive cells that co-localized with PCNA immuno-positive cells, indicating that *TopBP1*-null cells have survived and are replication competent ([Fig. 5e](#F5){ref-type="fig"}).

DNA strand breaks accumulate in TopBP1-null progenitors {#S7}
-------------------------------------------------------

Despite the rescue of developmental defects by p53 deficiency after TopBP1 inactivation, DNA damage was associated with TopBP1 loss and was frequently co-localized with proliferating cells ([Fig. 5e](#F5){ref-type="fig"} and [Suppl. Fig. 3 and 6a](#SD1){ref-type="supplementary-material"}). Although this reinforces the notion that TopBP1 is critical for maintaining genome stability but is dispensable for DNA replication, it raises the question of the physical nature of the DNA damage. As γH2AX is only a surrogate marker for DNA damage, we directly addressed DNA integrity in cortical progenitors *in situ* using the alkaline comet assay (ACA) to measure DNA strand breaks. We isolated progenitors from E13.5 neocortex from both *TopBP1^Nes-cre^* and *TopBP1^Emx1-cre^*;*p53^−/−^* and control embryos and then immediately subjected these to ACA. In this way we were able to directly assess DNA integrity *in vivo* at a specific developmental stage ([Fig. 6a](#F6){ref-type="fig"}). To determine the amount of strand breaks, we included an irradiated series of acutely isolated WT cerebellar granule neuron precursors (GNP) as a comparison to the cortical progenitors. We found that all individual cortical isolates from TopBP1 mutant tissue had markedly increased DNA strand breaks. The levels of DNA damage were similar to \~2Gy of radiation in GNPs ([Fig. 6a](#F6){ref-type="fig"}), which is estimated to be about 80 double-strand breaks/nucleus^[@R42]^, although the damage measured by the ACA also includes single-strand breaks. Notably, the levels of *in situ* DNA breaks were similar between cortical progenitors from *TopBP1^Nes-cre^* and *TopBP1^Emx1-cre^* progenitors indicating that both cre drivers are effective at TopBP1 deletion despite the more profound defects of cortical development in *TopBP1^Emx1-cre^* tissue.

Because TopBP1 deletion by either *Nes-cre* or *Emx1-cre* resulted in similar amounts of DNA damage in progenitors at E13.5, we determined the relative sensitivity of progenitor populations to DNA damage at different early embryonic developmental times. Using very low doses (0.2Gy) of ionizing radiation (IR) that generate \~8 breaks/G1-genome^[@R42]^ we quantified the levels of apoptosis by determining the ratio of TUNEL+ cells to total cells in a defined area in the ventricular zone of E11.5, E12.5 and E14.5 embryos. We found that there was a significantly enhanced susceptibility to DNA damage-induced apoptosis in early embryos compared with later-stage embryos, indicating a lower threshold for apoptosis in earlier progenitors compared with those generated later ([Fig. 6b](#F6){ref-type="fig"}).

Collectively these data indicate that TopBP1 deletion results in the accumulation and persistence of DNA strand breaks in cortical progenitors, and also that the relative levels of DNA damage are similar in *TopBP1^Emx1-cre^* and *TopBP1^Nes-cre^* progenitors. Thus the striking difference in phenotype after deletion via the different cre-drivers is not due to different amounts of DNA strand breaks, rather the enhanced susceptibility of earlier-born cortical progenitors to DNA damage after TopBP1 loss.

Defective DNA damage signaling in TopBP1 deficient cells {#S8}
--------------------------------------------------------

As TopBP1 loss resulted in elevated DNA damage, we determined the competency of TopBP1 deficient cells to respond to and repair DNA damage. We initially attempted to use *TopBP1^LoxP/LoxP^* mouse embryonic fibroblasts (MEFs) and retroviral transduction with MSCV-cre to delete *TopBP1*. However, retroviral introduction of cre caused widespread apoptosis of the *TopBP1^LoxP/LoxP^* cells after 48hrs, while *TopBP1^+/LoxP^* used as a control were unaffected by MSCV-cre. This likely reflects hypersensitivity of the *TopBP1*-deleted cells to DNA breaks associated with retroviral integration.

Therefore, we established *TopBP1^creTM^* cells in which TopBP1 can be inactivated after tamoxifen administration (creTM is a tamoxifen-inducible version of cre that uses the actin promoter and CMV enhancer). We found that efficient TopBP1 deletion occurred in *TopBP1^creTM^* MEFs after 4-hydroxytamoxifen (4-OHT) administration and that loss of TopBP1 resulted in a modest upregulation of p53, probably from replication-associated DNA damage ([Fig. 7a](#F7){ref-type="fig"}). After 4-OHT-mediated deletion (48hr treatment) *TopBP1^creTM^* MEFs ceased proliferation, although they remained viable. Using these, we found that loss of TopBP1 did not alter Chk2 activation or p53ser18 phosphorylation after DNA damage by IR. However, consistent with ATR activation requiring TopBP1, Chk1ser317 phosphorylation was reduced after radiation ([Fig. 7a](#F7){ref-type="fig"}, asterisk). As a comparison to the *in vitro* data, we examined the *TopBP1^Nes-cre^* cerebellum after radiation and found a similar defect in Chk1 phosphorylation to that in MEFs ([Fig. 7b](#F7){ref-type="fig"}). Overall, these data suggest that TopBP1 is not required for DNA double strand break (DSB) signaling, but rather is central to maintaining DNA integrity and ATR-dependent checkpoint activation during replication.

DNA repair is near normal in TopBP1 deficient cells {#S9}
---------------------------------------------------

We also determined DNA repair competency in TopBP1-depleted cells using primary *TopBP1^Nes-cre^* astrocytes challenged with IR or camptothecin. Although we were unable to establish *TopBP1^Nes-cre^* astrocytes, probably as a result of DNA damage induced cell cycle arrest, we were able to generate *TopBP1^Nes-cre^*;*p53^−/−^* astrocytes (that presumably overcame DNA damage-induced p53-dependent cell cycle arrest). However, compared with WT cultures, *TopBP1^Nes-cre^;p53^−/−^* astrocyte cultures only reached \~30 % confluency and were characterized by chronic DNA damage accumulation indicated by widespread γH2AX foci ([Fig. 7c](#F7){ref-type="fig"}). This DNA damage accumulation was associated with replication abnormalities, as BrdU/EdU incorporation in TopBP1 astrocytes showed a marked reduction compared with controls ([Fig. 7d](#F7){ref-type="fig"}, [Suppl. Fig. 8](#SD1){ref-type="supplementary-material"}).

Despite a normal IR-induced DNA damage response, the high endogenous levels of γH2AX indicated extensive DNA damage; most likely strand breaks associated with compromised replication. Therefore, we assessed DNA strand break repair after IR, by measuring resolution of the resultant γH2AX foci in *TopBP1^Nes-cre^;p53^−/−^* cells. We found that IR-induced γH2AX foci were resolved in *TopBP1^Nes-cre^;p53^−/−^* astrocytes suggesting that this type of exogenously induced DNA damage could be repaired effectively after TopBP1 loss ([Fig. 7e](#F7){ref-type="fig"}). Additionally, we measured DNA repair after genotoxic stress using the ACA. We found that while *TopBP1^Nes-cre^* cells had a higher basal level of DNA damage, these cells repaired DNA breaks at a rate similar to control cells after either IR or camptothecin. As a comparison to *TopBP1^Nes-cre^* we included DNA repair deficient tyrosyl-DNA phosphodiesterase 1 (*Tdp1^−/−^*) cells^[@R43]^ and confirmed that these were defective after both genotoxic agents ([Fig. 7f](#F7){ref-type="fig"}). Together, these data indicate that TopBP1 is not essential for repair of DNA strand breaks induced by agents that require BER and NHEJ/HR pathways. Thus, DNA strand break pathways are competent in TopBP1-null tissue, and the persistence of DNA breaks likely reflects excessive DNA damage accumulation and perturbed steady-state repair.

Discussion {#S10}
==========

Coordinated integration of DNA replication and damage signaling is necessary for unperturbed mammalian development. While our understanding of the biochemistry of DNA replication and repair has rapidly advanced during the last few years, it nonetheless remains a challenge to transition this knowledge to physiological systems. The nervous system is particularly relevant in this regard as it is often a primary tissue affected in human diseases associated with defects in the response to DNA damage^[@R5]^. In the present study we show that the ATR activator, TopBP1, is critical for the prevention of DNA damage accumulation and apoptosis in early-born neural progenitors, thereby maintaining homeostasis at a critical stage of nervous system development ([Suppl. Fig. 9](#SD1){ref-type="supplementary-material"}).

We found that TopBP1 inactivation by *Emx1-cre* in dorsal telencephalon progenitors during the very early stages of cortical neurogenesis (from \~E10) resulted in cortical ablation. In contrast, TopBP1 inactivation at later stages by *Nes-cre* resulted in less substantial defects in cortical development. The main reason for these different outcomes is the timing of cre-mediated deletion; *Emx1-cre* targets specific progenitors at least one day earlier than *Nes-cre*. Although *Emx1-cre* targets earlier-born cortical progenitors we found similar levels of DNA strand-breaks in dorsal telencephalon progenitors at E13.5 after TopBP1 inactivation by either cre-driver, indicating equivalent levels of damage. This raises the likelihood that there is a different threshold to DNA damage in the early-born progenitors, perhaps reflective of an increased need for vigilance of genome integrity in stem/early-progenitor populations. This assertion is supported by our finding of an increased sensitivity of cortical progenitors to DNA damage at E11 compared to E14. Indeed, although they cycle rapidly, early-born cortical progenitors have an extended S-phase that would allow enhanced genome surveillance and integrity. When switching to neuron production, S-phase shortens, suggesting genome maintenance is an important feature of uncommitted progenitors^[@R44]^. Additionally, as cortical expansion occurs G1 also lengthens in progenitors undergoing differentiation, highlighting the dynamic events associated with cell cycle regulation during neurogenesis^[@R36],\ [@R44],\ [@R45]^.

Altered transcriptional programming in cortical progenitors may also influence the outcome of genotoxic stress. For example, by the time they are targeted using *Nes-cre* the *Emx1*-expressing progenitor cells in the dorsal telencephalon have already undergone substantial expansion and cell fate determination by Lhx2 to commit to cortical genesis^[@R38]^. Therefore, progression from stem/uncommitted progenitor can result in altered cell cycle dynamics, intrinsic replication differences and differential sensitivity to DNA damage. In contrast to TopBP1, inactivation of the key DNA repair factors Xrcc1 and DNA Ligase IV by *Emx1-cre* failed to fully disrupt cortical genesis. This was also the case for Brca1 inactivation by *Emx1-cre*, although in that scenario early-born but not late-born progenitors were lost by apoptosis^[@R46]^. Taken together, one interpretation of our data is that the outcome of DNA damage is regulated differently as progenitors mature, and that TopBP1 contributes uniquely to genome stability in early-born progenitors. Alternatively, and despite equal levels of DNA strand breaks in both *TopBP1^Emx1-cre^* and *TopBP1^Nes-cre^* progenitors at E13.5, the greater cell loss in *TopBP1^Emx1-cre^* may reflect the more protracted period of proliferation prior to *Nes-cr*e expression.

The consequences of TopBP1 loss towards newborn progenitors in the cerebellum was similar to the cortex. *TopBP1^Nes-cre^* mice showed pronounced cerebellar agenesis, as the EGL failed to expand from the Rhombic lip. The cerebellar ventricular zone progenitors were also markedly affected, and the resultant lack of development lead to a cerebellum consisting of a disorganized collection of cells such as Purkinje cells that arise prior to *Nes-cre* activation.

While our data highlight the importance of TopBP1 for preventing replication-associated DNA damage, most prominently they show that it is not required *per se* for replication. This is because neural development defects in *TopBP1^Nes-cre^* or *TopBP1^Emx1-cre^* can be substantially rescued by concomitant p53 loss, leading to continued tissue development. These data contrast other studies that show TopBP1 is essential for the assembly of DNA replication pre-initiation complexes, a function tightly linked to factors such as Treslin/Ticrr and GEMC1^[@R6],\ [@R9],\ [@R10]^. The *in vivo* nature of our study maintains the physiological parameters that support development and cell proliferation, unlike other studies that utilize cell-free extracts or *in vitro* cell culture systems. However, consistent with those other studies, we find severely compromised proliferation of TopBP1-null cells in culture, and coincident inactivation of p53 is required to extend their viability. Nonetheless, *TopBP1^Nes-cre^*;*p53^−/−^* astrocytes can only undergo a few rounds of division, during which they accumulate abundant DNA damage.

While a key function of TopBP1 is activation of ATR, the more severe neurogenesis defects after TopBP1-loss than those of ATR inactivation^[@R47]^ argue for a broader role in genome maintenance. Furthermore, TopBP1-loss activated a DNA damage response resulting in p53-mediated apoptosis. This contrasts the different outcomes of Atr and p53 inactivation^[@R32],\ [@R33],\ [@R47]^, suggesting loss of TopBP1 in vivo results in DNA lesions and/or DNA damage signaling that are qualitatively different to those in Atr-deficient tissues. Although Atm can also be important in modulating p53-dependent DNA damage-induced apoptosis in the nervous system^[@R48]^, Atm loss failed to rescue defects in *TopBP1^Nes-cre^* mice. This is reflective of other scenarios in the nervous system whereby DNA damage leads to Atm-dependent apoptosis in immature post-mitotic neural cells, but not in proliferative cells^[@R49],\ [@R50]^.

Taken together, our data are compatible with a model in which TopBP1 maintains replication fidelity via checkpoint activation, rather than an essential role in replication pre-initiation complex assembly. In its absence replication proceeds, but DNA fidelity is compromised via the accumulation of stalled replication forks and other DNA damage during S-phase. This damage would normally signal ATR and other factors such as the BACH1 helicase^[@R30]^ for checkpoint activation and homologous recombination repair^[@R17]^. Thus, our study reveals the indispensible requirement for TopBP1 to prevent DNA damage accumulation in early-born progenitors, where maintenance of genome integrity is of paramount importance for neurogenesis.

Methods {#S11}
=======

TopBP1^LoxP^ mice {#S12}
-----------------

A targeting vector was constructed using recombineering to generate a *TopBP1* allele with exons 3--6 flanked by *LoxP* sites. To do this a single LoxP site was inserted between exons 2 and 3 and a neomycin-thymidine kinase selection cassette flanked by *Frt* sites with a single *LoxP* site was inserted between exons 6 and 7. The targeting construct was transfected into embryonic stem (ES) cells via electroporation and after selection with G418, homologous recombinants were screened by Southern blotting using both 3′ and 5′ probes outside the targeted region. Cells transfected with Flp recombinase were selected using FIAU to remove cells retaining the thymidine kinase and further screened by PCR using primers flanking the LoxP site or the LoxP/Frt remaining after recombination. Positive clones were blastocyst-injected to generate chimeric mice. The male chimeras were bred with C57BL/6 females to establish mice carrying the conditional *TopBP1* allele. Further breeding with cre mice under the control of the Nestin promoter (JAX \#003771: B6.Cg-Tg(Nes-cre)1Kln/J) resulted in deletion throughout the nervous system (<http://cre.jax.org/Nes/Nes-Cre.html>), while breeding with the Emx1-cre mice (JAX \#005628: B6.129S2-*Emx1^tm1(cre)Krj^*/J) deleted TopBP1 in Emx1 expressing neural progenitors (<http://cre.jax.org/Emx1/Emx1_cre.html>). CreTM mice (JAX \#004682: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J) provided tamoxifen inducible cre expression driven from the actin promoter and were used to obtain primary cell cultures. Other mice used were *p53^−/−^*, *Lig4^LoxP/LoxP^* and *Xrcc1^LoxP/LoxP^* have been described previously^[@R39],\ [@R40],\ [@R48]^. The *Atm* conditional allele was engineered to have exon 58 flanked by *LoxP* sites^[@R47]^. All animal experiments were carried out according to NIH regulations and were approved by the SJCRH animal care and use committee.

Histology {#S13}
---------

Mice were perfused transcardially or embryos were drop-fixed in 4 % buffered paraformaldehyde at several different time points, and cryoprotected in buffered 25% sucrose solution. Brains and embryos were sectioned at 10 μm sagittally or coronally using a HM500M cryostat (Microm). Nissl staining was carried out with 1 % (w/v) thionin, and hematoxylin/eosin staining was done according to standard procedures. Immunohistochemical and immunocytochemical staining of tissues and cells were carried out with the antibodies listed below. For colorimetric visualization of positive signals, sections were incubated with antibodies overnight at room temperature after quenching endogenous peroxidase using 0.6 % H~2~O~2~ in methanol. Slides were washed with phosphate-buffered saline (PBS) three times, followed by incubation with biotinylated secondary antibody and avidin-biotin complex (Vectastain Elite kit, Vector Labs). Antibodies were applied after citrate buffer--based antigen retrieval. Immunoreactivity was visualized with the VIP substrate kit (Vector Labs) using the manufacturer's protocol. After staining, sections were counterstained with 0.1 % methyl green, dehydrated, and mounted in DPX (Sigma). For immunofluorescence, FITC- or Cy3-conjugated secondary antibodies (Jackson Immunologicals) were used and counterstained with 4′6-diamidino-2-phenylindole (DAPI) or propidium iodide (Vector Laboratories). For immunohistochemistry and immunocytochemistry, we used the following antibodies at the indicated dilutions: anti-Calbindin (mouse, 1:2,000, Sigma), anti-PCNA (mouse, 1:500, Santa Cruz Biotechnology), anti-Pax2 (rabbit, 1:500, Zymed), anti-Ki67 (rabbit, 1:250, Vector Laboratories), anti-BrdU (Rat, 1:500, Oxford Biotechnology), anti-active Caspase-3 (rabbit, 1:100, BD Biosciences), anti-p53ser15 (rabbit, 1:100, Cell signaling; which recognizes mouse p53ser18), anti-pH2AXser139 (rabbit 1:500, Abcam), anti-pH3ser10 (rabbit, 1:500, Cell Signaling), anti-β Tubulin III (Tuj1, mouse, 1:500, BabCo), BLBP (brain lipid binding protein, rabbit, 1:300, Millipore), GFAP (Glial fibrillary acidic protein, mouse, 1:500, Sigma). Double immunohistochemistry of BLBP and γH2AX was differentially stained using donkey-FITC and goat-Cy3 secondary antibodies.

Layer markers for the cerebral cortex were: anti-Cux1 (CDP, rabbit, 1:100, Santa Cruz Biotechnology), anti-Brn2 (rabbit, 1:200, GeneTex), anti-Satb2 (mouse, 1:50, Abcam), anti-Tbr1 (rabbit, 1:100, Abcam), anti-Ctip2 (rat, 1:100, Abcam), anti-Tbr2 (rabbit, 1:200, Abcam), anti-Foxp1 (mouse, 1:50, Thermo Fisher Scientific), and anti-Foxp2 (rabbit, 1:50, Abnova). All antibodies except Cux1, Foxp1 and Foxp2 underwent the citrate buffer antigen-retrieval prior to the immunohistology procedure. Actin filaments in astrocytes were stained with phalloidin conjugated with Alexa Fluro 488 (Molecular Probes). For *in vivo* proliferation assays, newborn mice or pregnant females were intraperitoneal-injected with 5-bromo-2′-deoxyuridine (BrdU, 50μg/g body weight, Sigma-Aldrich). Embryos or brains were removed 2 h after BrdU injection and fixed in 4 % PBS-buffered paraformaldehyde. TUNEL analysis was performed using cryosections with the ApopTag^®^ fluorescein *In Situ* Apoptosis Detection Kit (CHEMICON) according the manufacturer's directions. Double-labeling of TUNEL with PCNA or BLBP was as described previously^[@R50]^.

Western blot analysis {#S14}
---------------------

Western blot analysis was done using astrocyte cell lines (genotypes as indicated in the main text and figures) at passage 1 or 2, or tissues (cortex, cerebellum, liver, thymus and spleen) from both P4/P5 control mice (*TopBP1^LoxP/+^;Nes-cre*) and conditional knockout mice (*TopBP1^Nes-cre^*). Protein extracts were prepared by using lysis buffer (50 mM Tris-HCl, 200 mM NaCl, 0.2 % NP-40, 1 % Tween-20, 1 mM NaF, 1 mM sodium vanadate, 50 mM β-glycerophosphate, 2 mM PMSF, and protease inhibitor cocktail (Roche)) and quantified using the Bradford assay (Bio-Rad). Proteins (50 μg per lane) were separated through a 4--12 % Bis-Tris SDS polyacrylamide gel (Invitrogen) and transferred onto nitrocellulose membrane (Bio-Rad). Blots were sequentially immunostained with mouse anti-TopBP1 antibody (rabbit, 1:1,000, Millipore/Chemicon) followed by horseradish peroxidase--conjugated secondary antibody (1:1,000, GE Healthcare) and detected using ECL Plus chemiluminescence (GE Healthcare). The blots were also probed with with anti-Nbs1 antibody (rabbit, 1:500, Cell Signaling), anti-Chk2 (mouse, 1:1000, Millipore), anti-p53ser15 (rabbit, 1:1,000 Bio-labs), anti-Chk1 (rabbit, 1:500, Cell Signaling), anti-pChk1ser317 (rabbit, 1:800, Bethyl) and processed as described above. Anti-actin (goat, 1:500, Santa Cruz Biotech) Western blots or Ponceau-stained transfer membrane were used as protein-loading controls.

Quantitative Real-Time PCR {#S15}
--------------------------

To confirm deletion of the *TopBP1* gene using *cre* lines (both *Emx1-* and *Nestin-cre*), genomic DNA was isolated at several different time points. For *Exm1-Cre*, the dorsal portion of the cerebral cortex was separated from the rest of brain. Similarly, the entire cerebral cortex was removed from the embryonic brain for *Nestin-cre*. Quantitative Real-time PCR using SYBR Green was performed according to the manufacturer's guideline (iQ5 multicolor real-time PCR detection system, Bio-Rad). Following primer sets were used to measure the quantity of exon 4 (targeted exon) and exon 11 of the *TopBP1* gene. The deletion efficiency was calculated as a ratio between exon 4 and exon 11. Each groups contained 2 to 4 embryos. The primers are; Exon 4 forward: 5′-GCGCCACCAGCAATGTG, Exon 4 reverse: 5′-TGTACAGGATACAGTTACGTCAGACATTA. Exon 11 forward: 5′-GCATGCTGGCAAGATTGTGT, Exon 11 reverse: 5′-CTTCCCAGCAGAATTGTTGCTGACTATGC. Real-time PCR for Xrcc1 and Lig4 were as described previously^[@R39],\ [@R40]^.

*In situ* cell counts {#S16}
---------------------

To determine cell cycle indices and apoptosis in *TopBP1^Nes-cre^* tissue during brain development, E13.5 embryos were subjected to quantitative analysis. Three embryos for each genotype were analyzed. Immunopositive signals for BrdU, PCNA, pH3ser10, TUNEL or active caspase-3 were measured within 1 or 0.27 mm^2^ from at least three representative sections of the neopallial cortex, cerebellum and ganglionic eminence per embryo. Similar quantification methods were applied to IR-induced apoptosis (TUNEL) in embryos collected 6 hs after 0.2 Gy IR at E11.5, E12.5 and E14.5. In this case, the ratio of TUNEL positive signals to propidium iodide (PI) positive neurons was calculated using ImageJ (1.46b, NIH), and analyzed using Prism v4 software (Graphpad)..

Isolation of primary astrocytes and embryonic fibroblasts {#S17}
---------------------------------------------------------

Primary astrocytes were prepared from P1-P2 mouse brains. Cortices were dissociated by passage through a 5 ml pipette and cells were suspended in Dulbecco's modified Eagle's medium and Ham's nutrient mixture F-12 (1:1 DMEM/F12, Gibco-BRL) supplemented with 10 % fetal bovine serum (v/v), 100 U/ml penicillin, 100μg/ml streptomycin and 20 ng/mlepidermal growth factor (Millipore). Primary astrocytes were established in Primeria T-25 tissue culture flasks (Falcon) at 37° C in a humidified CO~2~-regulated (5 %) incubator. Mouse embryonic fibroblasts (MEFs) were isolated from E13.5 embryos and grown at 37° C in DMEM/10 % FCS supplemented with β-mercaptoethanol in a humidified CO~2~-regulated (5%) incubator.

For DNA replication analysis, astrocytes were cultured in the presence of 10 μm BrdU (Sigma). Five days later cells were trypsinize, resuspended in media containing BrdU and seeded onto 1 mm glass coverslips (Fisher) at \~20 % confluency. Twenty hours later, the BrdU-enriched media was removed and cells were incubated with pre-warmed media alone (0 min) or media containing 10 μm EdU (Invitrogen) for 15, 30 or 60 mins. Cells were then washed, fixed in 4 % PBS-buffered paraformaldehyde and permeabilized with 0.5 % PBS-buffered Triton X-100. Labeling of EdU was performed using the Click-It EdU Alexa 488-azide detection kit (Invitrogen) using the manufacturer's suggested protocol. Cells were then treated with 2 N HCl for 30 mins at 37° C and then immunostained with Alexa 555-conjugated anti-BrdU antibody (Invitrogen, 1:500, clone MoBU-1). Cells were counterstained with 4′6-diamidino-2-phenylindole (DAPI; Vector Laboratories). Cells counts were analyzed using a student t-test.

Comet Assays {#S18}
------------

Quiescent primary astrocytes were treated with either 14μM camptothecin for 60 mins at 37° C or γ irradiation (20Gy, Cs^137^). Following treatments, cells were incubated for various times in drug-free medium at 37° C to assess recovery from damage. Cells were trypsinized and suspended in pre-chilled PBS, mixed with an equal volume of 1.2 % low-melting point agarose (Invitrogen), maintained at 42° C and immediately layered onto frosted glass slides (Fisher) pre-coated with 0.6 % agarose and maintained in the dark at 4°C for all subsequent steps. Slides were immersed in pre-chilled lysis buffer (2.5 M NaCl, 10 mM Tris-HCl, 100 mM EDTA (pH 8.0), 1 % (v/v) Triton X-100, 3 % (v/v) DMSO, pH10) for 1h, washed with pre-chilled distilled water (twice for 10 min each) and placed into pre-chilled alkaline electrophoresis buffer (50 mM NaOH, 1 mM EDTA, 1 % DMSO) for 45 min. Electrophoresis was carried out at 95 mA for 25 min, followed by neutralization in 0.4 M Tris-HCl (pH 7.0). Comets were stained with SYBR Green (1:10,000 in PBS, Sigma) for 10 min. Experiments were performed in triplicate and a minimum of 100 comet tail moments were measured using the Comet Assay IV system (Perceptive Instruments) coupled to an Axioskop2-plus microscope (Zeiss) at 200x magnification.

For *in vivo* comet analysis, tissue from E13.5 embryonal dorsal telencephalon was triturated into a single-cell suspension in pre-chilled PBS-buffered 2 % glucose. Cells were embedded into LMP agarose and underwent alkaline comet analysis as outlined above. Samples were prepared and analyzed from every embryo collected and genotyping was done post-experimentally ensuring a blinded analysis of strand break levels. Cerebellar granule neurons were prepared from P6 WT mice via a percoll gradient as previously described^[@R43]^; neurons were irradiated on ice at the specified dose rate and immediately embedded into agarose for alkaline comet analysis. At least 300 comet tail moments were measured from each sample.

Statistical analysis {#S19}
--------------------

Cell counts were determined using a student t-test and were calculated using Prism V4 software (Graphpad); P\<0.05 was considered significant. Box plots representing comet data were calculated using Deltagraph 6 (Redrock software) from tail moment data generated using the Comet Assay IV system (Perceptive Instruments).
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![*TopBP1* deletion in the nervous system\
(a) TopBP1 contains eight BRCA1 C-terminal (BRCT) domains. These encompass an amino terminal TRESLIN/Ticrr interacting domain, a C-terminal ATR-activating, a BACH1-binding region and an ATM phosphorylation site in BRCT domain 5. A conditional *TopBP1* allele has *LoxP* sites flanking exons 3 and 6 and generates an out-of-frame mutation after cre-mediated recombination. (b) TopBP1 protein is absent in P0 *TopBP1^Nes-cre^* brain tissues but is present at normal levels in the thymus and spleen, while Nbs1 and actin levels are similar in all mutant tissues. (c) *TopBP1^Nes-cre^* neonates (asterisks) are initially similar to littermate controls, but become runted by P4. (d) The *TopBP1^Nes-cre^* cerebellum lacks granule neurons resulting in a disorganized Purkinje cell placement as shown at P0 using calbindin staining and at P12 using the neuronal differentiation marker βtubulin III (Tuj1). (e) Quantitative real-time PCR shows *TopBP1* deletion occurs by E12.5 in the cortex but not the liver. (f) Western blot analysis of E14.5 *TopBP1^Nes-cre^* tissues shows that TopBP1 is deleted in the cortex but not the liver; p53pSer18 expression is also elevated in *TopBP1^Nes-cre^* tissue. Nbs1 and Ponceau staining are loading and blotting controls, respectively. (g) Apoptosis (arrows) occurs in proliferating cells in the developing cortex at E13.5.](nihms367465f1){#F1}

![Apoptosis and cortical layering disruption in the *TopBP1^Nes-cre^* brain\
(a) Apoptosis in the *TopBP1^Nes-cre^* E16.5 cortex is associated with PCNA+ proliferating cells but not BLBP+ radial glia progenitors. (b) Apical progenitors (arrows) were identified using H3pSer10 immunostaining in E13.5 *TopBP1^Nes-cre^* and control neocortex. (c) Analysis of cortical development in P0 and P10 *TopBP1^Nes-cre^* and *WT* tissue using Tbr1 and Ctip2 to mark layers VI-IV, Cux1 to identify layers IV-II and Brn2/Satb2 to identify layers V-II reveals disrupted layer development in the *TopBP1^Nes-cre^* cortex. VZ is ventricular zone. Capital Roman numerals indicate the cortical layers.](nihms367465f2){#F2}

![Dorsal telencephalon progenitors are lost in *TopBP1^Emx1-cre^* mice\
(a) Cortices and other structures developing from the dorsal telencephalon are missing in the *TopBP1^Emx1-cre^* brain; shown by Nissl staining at P5. CC is the corpus callosum, hippo is the hippocampus and RMS is the rostral migratory stream. (b) Abundant apoptosis is observed in the E13.5 *TopBP1^Emx1-cre^* neopallial cortex shown using TUNEL and activated caspase-3 staining. Differences in the numbers of apoptotic cells between genotypes calculated using a student's t-test were significantly different; active caspase 3 positive cells in 1 mm^2^ (± SEM) were; control = 0; *TopBP1^Emx1-cre^* = 734.5 (± 30.58), and TUNEL positive cells in 1 mm^2^ (± SEM) were; control = 7 (± 0.81) and *TopBP1^Emx1-cre^* = 987.5 (± 27.381). (c) Fewer proliferating cells indicated by histone H3pSer10 or BrdU incorporation staining are seen in the E13.5 *TopBP1^Emx1-cre^* neopallial cortex. Differences in the numbers of proliferating cells between genotypes calculated using a t-test were significantly different; BrdU positive cells in 0.27 mm^2^ (± SEM) were; control = 438.4 (±26.48) *TopBP1^Emx1-cre^* = 205.6 (± 10.31) and H3pS10 positive cells in 1 mm^2^ (± SEM) were; control = 91 (± 4.589), *TopBP1^Emx1-cre^* = 27.69 (± 1.707). Widespread DNA damage shown by γH2AX and PCNA immunostaining in regions indicated in white boxes in adjacent panels.](nihms367465f3){#F3}

![Analysis of cortical development in *Lig4^Emx1-cre^* and *Xrcc1^Emx1-cre^* brain\
(a) Nissl staining identifies the *Lig4^Emx1-cre^* and *Xrcc1^Emx1-cre^* cortex (Ctx) and hippocampus (DG and CA1) and shows the relative levels of defective development after Lig4 or Xrcc1 loss. Relative gene deletion (± SEM) was determined in genomic DNA isolated from the cortex using realtime PCR. For *Xrcc1*; WT = 1.22 (± 0.033), *Xrcc1^Emx1-cre^* = 0.46 (± 0.006). For *Lig4*; WT = 0.86 (± 0.038), *Lig4^Emx1-cre^* = 0.19 (± 0.004). Tbr2 marks the dentate gyrus (DG). (b) Cortical markers were used to assess development in the *Lig4^Emx1-cre^* and *Xrcc1^Emx1-cre^* cortex. Roman numerals indicate the cortical layers. (c) DNA damage (γH2AX) accumulates in the *Lig4^Emx1-cre^* cortex; DG is the dentate gryus.](nihms367465f4){#F4}

![Defective neurogenesis after *TopBP1* inactivation requires p53, but not Atm signaling\
(a) The hippocampal defects in *TopBP1^Nes-cre^* brain involve p53 signaling as *TopBP1^Nes-cre^;p53^−/−^* mice show partial rescue of hippocampal dentate gyrus development as shown using calbindin immunostaining to assess histology at postnatal day 5 (P5). In contrast to p53, Atm loss failed to rescue defective *TopBP1^Nes-cre^* hippocampal development. Despite recovered development, TopBP1 loss nonetheless resulted in persistent DNA damage as demonstrated by γH2AX foci. (b) Analysis of apoptosis using TUNEL or proliferation using H3pSer10 indicates that p53, but not Atm signaling is involved in the *TopBP1^Nes-cre^* phenotype. (c) Cortices that fail to develop in *TopBP1^Emx1-cre^* mice are rescued by coincident loss of p53 (red-hatched outlines). However, the hippocampal formation is not rescued in the *TopBP1^Emx1-cre^;p53^−/−^* brain. (d) Although substantial cortical rescue occurs in *TopBP1^Emx1-cre^;p53^−/−^* mice, cortical layering shows disorganization as indicated using Cux1 or Tbr1 and Ctip2 co-staining. (e) DNA damage is present throughout the P5 *TopBP1^Emx1-cre^;p53^−/−^* cortices (arrows) and γH2AX foci are frequently observed in PCNA-positive proliferating cells (arrowhead); P5 is postnatal day 5. DG is dentate gyrus.](nihms367465f5){#F5}

![TopBP1-deficiency during neurogenesis results in DNA strand break accumulation in cortical progenitors\
(a) Embryonal neural cells isolated from *TopBP1^Nes-cre^* and *TopBP1^Emx1-cre^* accumulate significant DNA damage compared to wild type controls. Comet analysis of acutely isolated cells from E13.5 *TopBP1^Nes-Cre^* (dark blue; six individual *TopBP1^Nes-cre^* embryo isolates and brown is data from a *TopBP1^Nes-cre^*;*p53^−/−^* embryo) or *TopBP1^Emx1-cre^;p53^−/−^* (light blue; six individual embryos) dorsal telencephalon show accumulated DNA damage *in situ* compared to controls (mauve; 14 individual embryo isolates); a minimum of 300 comet-tail moments were measured for each sample and mean comet-tail moments for each replicate are shown. Mean comet tail moments of irradiated P6 cerebellar granule neurons at increasing doses (orange) are shown in comparison as a standard to quantify DNA strand breaks. Inset scatterplots indicate actual comet tail moment values of 100 representative cells analyzed from the respective genotypes. The inset boxplot indicates the mean comet tail moment of all replicates within each genotype. (b) Cortical progenitors at E11.5 and E12.5 are significantly more susceptible to DNA damage-induced apoptosis than at those at E14.5. Quantitation of TUNEL positive cells was determined in proportion to propidium iodide-stained cells in the neocortex after 0.2Gy of radiation. VZ is ventricular zone.](nihms367465f6){#F6}

![Analysis of DNA damage responses in TopBP1-depleted cells\
(a) The radiation-induced DNA damage response was investigated using tamoxifen (4-OHT)-induced deletion of *TopBP1* in mouse embryonic fibroblasts (MEFs): WT are *TopBP1^+/+^*;*Cre^TM^* and KO are *TopBP1^LoxP/LoxP^*;*Cre^TM^*. TopBP1, Chk2, p53(p-ser18), Chk1(p-ser317) and actin indicate the result of probing with the respective antibodies. Activation of Chk2 is indicated by mobility shift (arrow). Ponceau staining and actin immunostaining indicates protein loading. Asterisk indicates decreased Chk1(p-ser317) immunostaining after TopBP1 inactivation. (b) Cerebellar extracts or astrocytes were from wild type or *TopBP1^Nes-cre^* mice and were immunoblotted as described above for MEFs, but also included antibodies recognizing total Chk1 and glial fibrillary acidic protein (GFAP); longer exposure reveals clear GFAP staining in the cerebellum (not shown). Trace TopBP1 signal in replication-defective null-astrocytes is from meningeal fibroblast contamination. Radiation was 4Gy with 2h recovery. (c) *TopBP1^Nes-cre^;p53^−/−^* astrocytes show elevated levels of endogenous DNA damage indicated by γH2AX immunostaining (arrows). Astrocyte purity is shown by GFAP immunostaining. (d) DNA replication in control and *TopBP1^Nes-cre^*:*p53^−/−^* astrocytes was determined using EdU pulsing after BrdU pre-labeling. TopBP1 deficiency markedly compromised DNA replication as shown by a significant reduction of EdU uptake; \*= p\<0.001. (e) DNA repair in *TopBP1^Nes-cre^;p53^−/−^* astrocytes determined by quantifying γH2AX foci removal after IR (n=50 cells); R0 and R240 represent recovery after 0 and 240 minutes. (f) DNA repair was assessed after IR (10 Gy) and camptothecin (14μM) using the alkaline comet assay; *Tdp1^−/−^* primary astrocytes were established from tyrosyl-DNA phosphodiesterase- 1 null mice. R60 represents recovery after 60 minutes.](nihms367465f7){#F7}
